GA, C., A, K., CW, C., ES, Y., & M, B. (2022). Excipient lung disease secondary to intravenous heroin use. BMJ case reports, 15(4), . https://doi.org/10.1136/bcr-2021-247763
Chicago Style (17th ed.) CitationGA, Colbenson, Kubbara A, Cox CW, Yi ES, and Baqir M. "Excipient Lung Disease Secondary to Intravenous Heroin Use." BMJ Case Reports 15, no. 4 (2022). https://doi.org/10.1136/bcr-2021-247763.
MLA (9th ed.) CitationGA, Colbenson, et al. "Excipient Lung Disease Secondary to Intravenous Heroin Use." BMJ Case Reports, vol. 15, no. 4, 2022, https://doi.org/10.1136/bcr-2021-247763.
Warning: These citations may not always be 100% accurate.